MADIT ASIA Cardiac Resynchronization Trial

PHASE3TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Congestive Heart FailureLeft Bundle Branch BlockHeart Failure, Systolic
Interventions
DEVICE

Two-lead CRT-P

The two lead CRT-P will consist of a dual chamber pacemaker, a right atrial lead and a left ventricular lead.

Trial Locations (21)

Unknown

Grantham Hospital, Hong Kong

Queen Mary Hospital, Hong Kong

Prince of Wales Hospital, Shatin

Fu Wai Hospital, Beijing

Zhejiang hospital Hangzhou, Hangzhou

Zhongshan hospital Shanghai, Shanghai

Medanta-Medicity, Gurgaon

Fortis Escorts Health Institute, New Delhi, New Delhi

CARE Hospital Nampally, Hyderabad, Hyderabad

Tokyo Women's Medical Univesity Hospital, Shinjuku

Okayama University Hospital, Okayama

Institut Jantung Negara, Kuala Lumpur

National Heart Center, Singapore

National University Heart Center Singapore, Singapore

Tan Tock Seng Hospital, Singapore

Korea University Medical Center, Seoul

Seoul ASAN Medical Center, Seoul

Yonsei University Medical Center - Severance Hospital, Seoul

Chang Gung Memorial Hospital, Linkou District

Her Majesty's Cardiac Center, Siriraj Hospital, Mahidol University, Bangkok

Ramathibodi Hospital, Mahidol University, Bangkok

Sponsors
All Listed Sponsors
collaborator

University of Rochester

OTHER

lead

Boston Scientific Corporation

INDUSTRY

NCT01872234 - MADIT ASIA Cardiac Resynchronization Trial | Biotech Hunter | Biotech Hunter